Husebye E S, Boe A S, Rorsman F, Kämpe O, Aakvaag A, Rygh T, Flatmark T, Haavik J
Division of Endocrinology, Institute of Medicine, University of Bergen, Bergen, Norway.
Clin Exp Immunol. 2000 Jun;120(3):420-3. doi: 10.1046/j.1365-2249.2000.01250.x.
A full-length rat cDNA clone encoding aromatic L-amino acid decarboxylase (AADC) (E.C. 4.1.1.28) was used for in vitro transcription and translation. The enzyme had catalytic activity (0. 2 pmol serotonin/microl lysate per min), and was stimulated 2.5-fold by the addition of excess pyridoxal phosphate. On size exclusion chromatography, AADC eluted as a single activity peak with an apparent mol. wt of 93 kD. This activity peak was immunoprecipitated by sera from patients with autoimmune polyendocrine syndrome type I (APS I) containing autoantibodies against AADC. Serum and purified IgG from these patients inhibited the enzyme activity (non-competitively) by 10-80%, while sera from APS I patients without autoantibodies and controls did not. This finding confirms and extends previous observations that APS I patients have inhibitory antibodies against key enzymes involved in neurotransmitter biosynthesis.
一个编码芳香族L-氨基酸脱羧酶(AADC)(E.C. 4.1.1.28)的全长大鼠cDNA克隆用于体外转录和翻译。该酶具有催化活性(每分钟每微升裂解物产生0.2皮摩尔血清素),并且通过添加过量的磷酸吡哆醛可使其活性提高2.5倍。在尺寸排阻色谱上,AADC以单一活性峰洗脱,表观分子量为93 kD。该活性峰被来自I型自身免疫性多内分泌综合征(APS I)患者且含有抗AADC自身抗体的血清免疫沉淀。这些患者的血清和纯化的IgG(非竞争性地)抑制酶活性10%-80%,而来自无自身抗体的APS I患者和对照组的血清则无此作用。这一发现证实并扩展了先前的观察结果,即APS I患者具有针对神经递质生物合成中关键酶的抑制性抗体。